Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-01-01 @ 4:59 PM
Study NCT ID:
NCT01734057
Status:
WITHDRAWN
Last Update Posted:
2016-04-20
First Post:
2012-11-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Sponsor:
Shandong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-07
Start Date Type:
None
Primary Completion Date:
2013-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2013-10
Completion Date Type:
ESTIMATED
First Submit Date:
2012-11-21
First Submit QC Date:
None
Study First Post Date:
2012-11-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-04-18
Last Update Post Date:
2016-04-20
Last Update Post Date Type:
ESTIMATED